Apollo Medical Holdings Inc
F:3AM

Watchlist Manager
Apollo Medical Holdings Inc Logo
Apollo Medical Holdings Inc
F:3AM
Watchlist
Price: 38.4 EUR -1.03%
Market Cap: €1.9B

Wall St Price Targets

3AM Price Targets Summary
Apollo Medical Holdings Inc

Wall Street analysts forecast 3AM stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 3AM is 20.74 EUR with a low forecast of 18.3 EUR and a high forecast of 23.2 EUR.

Lowest Forecast
Price Target
18.3 EUR
52% Downside
Average Forecast
Price Target
20.74 EUR
46% Downside
Highest Forecast
Price Target
23.2 EUR
40% Downside
Apollo Medical Holdings Inc Competitors:
Price Targets

Revenue
Forecast

42% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat
42% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat

Over the last 4 years, the compound annual growth rate for Revenue has been 42%. The projected CAGR for the next 6 years is 11%.

Gross Profit
Forecast

18% / Year
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss
18% / Year
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Over the last 4 years, the compound annual growth rate for Gross Profit has been 18%. The projected CAGR for the next 3 years is 16%.

Operating Income
Forecast

0% / Year
Past Growth
25% / Year
Estimated Growth
Estimates Accuracy
-14%
Average Miss
0% / Year
Past Growth
25% / Year
Estimated Growth
Estimates Accuracy
-14%
Average Miss

Over the last 4 years, the compound annual growth rate for Operating Income has been 0%. The projected CAGR for the next 6 years is 25%.

Pre-Tax Income
Forecast

-16% / Year
Past Growth
62% / Year
Estimated Growth
Estimates Accuracy
-19%
Average Miss
-16% / Year
Past Growth
62% / Year
Estimated Growth
Estimates Accuracy
-19%
Average Miss

Over the last 4 years, the compound annual growth rate for Pre-Tax Income has been -16%. The projected CAGR for the next 3 years is 62%.

Net Income
Forecast

-24% / Year
Past Growth
68% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss
-24% / Year
Past Growth
68% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Over the last 4 years, the compound annual growth rate for Net Income has been -24%. The projected CAGR for the next 3 years is 68%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 3AM's stock price target?
Price Target
20.74 EUR

According to Wall Street analysts, the average 1-year price target for 3AM is 20.74 EUR with a low forecast of 18.3 EUR and a high forecast of 23.2 EUR.

What is the Revenue forecast for Apollo Medical Holdings Inc?
Projected CAGR
11%

Over the last 4 years, the compound annual growth rate for Revenue has been 42%. The projected CAGR for the next 6 years is 11%.

What is the Gross Profit forecast for Apollo Medical Holdings Inc?
Projected CAGR
16%

Over the last 4 years, the compound annual growth rate for Gross Profit has been 18%. The projected CAGR for the next 3 years is 16%.

What is the Operating Income forecast for Apollo Medical Holdings Inc?
Projected CAGR
25%

Over the last 4 years, the compound annual growth rate for Operating Income has been 0%. The projected CAGR for the next 6 years is 25%.

What is the Pre-Tax Income forecast for Apollo Medical Holdings Inc?
Projected CAGR
62%

Over the last 4 years, the compound annual growth rate for Pre-Tax Income has been -16%. The projected CAGR for the next 3 years is 62%.

What is the Net Income forecast for Apollo Medical Holdings Inc?
Projected CAGR
68%

Over the last 4 years, the compound annual growth rate for Net Income has been -24%. The projected CAGR for the next 3 years is 68%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett